Supplier Presentation Theater Session – NMNH: The next-gen super NAD+ booster

Discover how NMNH, the reduced form of NMN (nicotinamide mononucleotide), is revolutionizing the way we approach healthy aging. This presentation will introduce the relationship between NAD+ (nicotinamide adenine dinucleotide) and age-related health, highlighting NMNH's potential to restore NAD+ levels effectively. We will also share the latest findings from both human clinical and preclinical studies showcasing the efficacy and safety of NMNH, and explore market applications for this innovative ingredient. Perfect for those interested in the latest advancements in healthy aging and wellness.  

Speaker Information:
Richard H. Kaszynski, M.D., Ph.D.
Co-founder and director, Stanford Solutions 
Trustee, the ASHINAGA organization